Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers N > Headlines for Neuralstem Inc. > News item |
Neuralstem plans $20 million at-the-market sales through T.R. Winston
Agent to receive 4% commission; deal funds general corporate purposes
By Devika Patel
Knoxville, Tenn., Jan. 30 – Neuralstem Inc. arranged a $20 million at-the-market offering with agent T.R. Winston & Co., LLC, according to a prospectus supplement filed Friday with the Securities and Exchange Commission.
T.R. Winston will be paid a 4% commission.
Proceeds will be used for general corporate purposes, including working capital, capital expenditures, research and development expenditures, clinical trials, acquisitions and investments.
Based in Rockville, Md., Neuralstem develops technologies to transplant human neural stem cells.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.